Biotechnology Stocks I Performance Guide: Halozyme Therapeutics, Inc. (HALO)
HALO has no dividends
Table and Chart of HALO Performance
See what a $1,000 investment in HALO is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| HALO Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $14.99 |
| End Date | Dec-01-2023 |
| End Price | $39.69 |
| # Prices | 121 |
| Min Date | Apr-30-2014 |
| Min Price | $7.45 |
| Max Date | Nov-30-2022 |
| Max Price | $57.26 |
| Total Return | 164.78% |
| Annualized Return | 10.14% |
| Current Value of $1,000 Purchase | $2,648 |
| Number Returns | 7,260 |
| Average Return | 104.51% |
| Number Profitable Returns | 5,952 |
| Percent Profitable Returns | 81.98% |
| Number Unprofitable Returns | 1,308 |
| Percent Unprofitable Returns | 18.02% |
| Profitable to Unprofitable Returns Ratio | 4.55 |
| HALO Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $5,244,279,000 | Price to Sales | 6.72 |
| Earnings per Share | $1.8700 |
| PE Ratio | 21.22 |
| PE to Growth Ratio | -2.5 |
| Price to Book | 21.04 |
| PRICE DATA | |
| 52 Week High | $59.4 |
| 52 Week Low | $29.85 |
| Analyst Target Price | $51.27 |
| 50-Day Moving Average | $37.34 |
| 200-Day Moving Average | $38.16 |
| FINANCIAL DATA | |
| Revenue per Share | $5.85 |
| Revenue | $780,710,000 |
| Profit Margin | 32.5% |
| Return on Equity | 1.467% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
HALO Compare Returns with S&P 500
HALO Trendline Chart